The new standard of care.
A concussion is a brain injury, so we need to critically evaluate the brain’s health to localize and measure the impact of each injury. With this information, you can design targeted treatment plans and evaluate progress to improve results and recovery timelines.

Why choose NeuroFlex®

Objective, quantitative measurements

Today’s athletes are smart. They want to see something concrete when they’re told to stay off the field for a concussion. NeuroFlex® provides objective measurements of brain health, so you can show your patients exactly how they’re doing, and you can know when they’re ready to get back on the field.

Track recovery up to months after injury

Most concussion tests stop working within a short period after the initial injury. This means there’s no way to know if someone is getting better over time. For people with lasting symptoms, this is incredibly frustrating. NeuroFlex® measures brain function health objectively by looking at pure reflexes, so it doesn’t lose accuracy or sensitivity over time. This means that you can track patient progress at every step of recovery.

Develop personalized treatment plans

With the ability to track your patients over time, you can adjust their treatment protocols with real data on their rate of improvement. Reports at regular intervals take only a few minutes, and they provide a quantitative guide to help you provide superior care and patient satisfaction. Be a part of the new standard of care and start using NeuroFlex® in your clinic today.

Based on scientific expertise

NeuroFlex® is the product of over 60 years of experience in eye and head movement analysis. Mimi Galiana, our Chief Scientific Officer, is a leading expert in the field, with over 200 publications on the subject in top peer reviewed journals. When you go with NeuroFlex®, you know you’re backed by expertise.

More questions?

Interested in the scientific basis?


1. Oculomotor cognitive control abnormalities in Australian rules football players with a history of concussion.” Journal of neurotrauma 35.5 (2018): 730-738.
2. Wallace, Jessica, et al. “Disparities on baseline performance using neurocognitive and oculomotor clinical measures of concussion.” The American Journal of Sports Medicine 48.11 (2020): 2774-2782.
3. Henry, Luke C., et al. “Examining recovery trajectories after sport-related concussion with a multimodal clinical assessment approach.” Neurosurgery 78.2 (2016): 232-241.
4. Vernau, Brian T., et al. “Oculomotor and neurocognitive assessment of youth ice hockey players: baseline associations and observations after concussion.” Developmental neuropsychology 40.1 (2015): 7-11.